Stemina Biomarker Discovery
Biotechnology, 200 Campbell Dr Ste 200, Madison, Wisconsin, 08046, United States, 11-50 Employees
Phone Number: 60********
Who is STEMINA BIOMARKER DISCOVERY
Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers to improve drug safety and human health. Stemina...
Read More
-
Headquarters: 200 Campbell Dr Ste 200, Madison, Wisconsin, 08046, United States
-
Date Founded: 2007
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 6512
|
NAICS Code: 999990 |
Show More
Does something look wrong? Fix it. | View contact records from STEMINA BIOMARKER DISCOVERY
Stemina Biomarker Discovery Org Chart and Mapping
Email
Phone
Similar Companies to Stemina Biomarker Discovery
FUJIFILM Cellular Dynamics
-
51-200
-
$ 100 Million to 250 Million
Nexcyon Pharmaceuticals
-
11-50
-
$ Under 1 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Stemina Biomarker Discovery
Answer: Stemina Biomarker Discovery's headquarters are located at 200 Campbell Dr Ste 200, Madison, Wisconsin, 08046, United States
Answer: Stemina Biomarker Discovery's phone number is 60********
Answer: Stemina Biomarker Discovery's official website is https://stemina.com
Answer: Stemina Biomarker Discovery's revenue is $10 Million to $25 Million
Answer: Stemina Biomarker Discovery's SIC: 6512
Answer: Stemina Biomarker Discovery's NAICS: 999990
Answer: Stemina Biomarker Discovery has 11-50 employees
Answer: Stemina Biomarker Discovery is in Biotechnology
Answer: Stemina Biomarker Discovery top competitors include: FUJIFILM Cellular Dynamics , Nexcyon Pharmaceuticals
Answer: Stemina Biomarker Discovery contact info: Phone number: 60******** Website: https://stemina.com
Answer: Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers to improve drug safety and human health. Steminas cell based assays arise from the strategic convergence of two cutting edge technologies: human embryonic stem (hES) cells and metabolomics. Stemina uses mass spectrometry to analyze the small molecules secreted by hES cells, and differentiated cells such as heart and neural cells made from hES cells, in response to drugs, injury or disease. Stemina opened its state-of-the-art facilities for hES cell culture and mass spectrometry in the UW Research Park in Madison Wisconsin on November 1, 2007.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month